Lantern Pharma
(NASDAQ) LTRN
Lantern Pharma Financials at a Glance
Market Cap
$18.23M
Revenue (TTM)
$0.00
Net Income (TTM)
$17.12B
EPS (TTM)
$-1.57
P/E Ratio
-1.03
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$1.60
Volume
10,739
Open
$1.59
Price
$1.60
Volume
10,739
Open
$1.59
Previous Close
$1.60
Daily Range
$1.51 - $1.64
52-Week Range
$1.11 - $5.74
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$1.60
Volume
10,739
Open
$1.59
Previous Close
$1.60
Daily Range
$1.51 - $1.64
52-Week Range
$1.11 - $5.74
LTRN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lantern Pharma
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Panna L. Sharma
Website
www.lanternpharma.comHeadquarters
Dallas, TX 75201, US
LTRN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-124%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-97.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.23M
Shares Outstanding
11.25M
Volume
10.74K
Short Interest
0.00%
Avg. Volume
509.37K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$17.98B
EBITDA
$17.96M
Operating Cash Flow
$15.68B
Capital Expenditure
$1.72K
Free Cash Flow
$15.68B
Cash & ST Invst.
$10.12B
Total Debt
$78.54M
Lantern Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$4.10K
+108.0%
Gross Margin
0.00%
N/A
Market Cap
$18.23M
N/A
Market Cap/Employee
$759.69K
N/A
Employees
24
N/A
Net Income
$17.11B
-291062.7%
EBITDA
$4.20M
+27.9%
Quarterly Fundamentals
Net Cash
$10.04B
+42142.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$78.54M
+41060.0%
Return on Assets
-1.55%
N/A
Return on Invested Capital
-2.75%
N/A
Free Cash Flow
$15.66B
-393978.1%
Operating Cash Flow
$15.66B
-394284.1%